| Date Filed | Type | Description |
| 05/12/2023 |
4
| Guyer Shelly D (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
| 05/12/2023 |
4
| RIEFLIN WILLIAM JL (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
| 05/12/2023 |
4
| Hooper Suzanne Sawochka (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
| 05/12/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
| 05/12/2023 |
4
| PERLMUTTER ROGER M (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
| 05/12/2023 |
4
| Ho Carole (Director) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 78,407 options to buy
@ $3.69, valued at
$289.3k
|
|
| 03/06/2023 |
4
| Nolan Mangini Siobhan (President and CFO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 76,000 shares
@ $0
Granted 228,000 options to buy
@ $4.36, valued at
$994.1k
Granted 200,000 options to buy
@ $4.36, valued at
$872k
|
|
| 03/06/2023 |
4
| WOODHOUSE DAVID J (CEO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 127,200 shares
@ $0
Granted 381,600 options to buy
@ $4.36, valued at
$1.7M
Granted 500,000 options to buy
@ $4.36, valued at
$2.2M
|
|
| 03/06/2023 |
4
| Lieu Hsiao D (SVP, Chief Medical Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 53,000 shares
@ $0
Granted 159,000 options to buy
@ $4.36, valued at
$693.2k
|
|
| 03/06/2023 |
4
| CHEN JIN-LONG (Chief Scientific Officer) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 64,000 shares
@ $0
Granted 192,000 options to buy
@ $4.36, valued at
$837.1k
Granted 175,000 options to buy
@ $4.36, valued at
$763k
|
|
| 03/06/2023 |
4
| Pierce Valerie L (SVP, GC & CCO) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Granted 49,000 shares
@ $0
Granted 147,000 options to buy
@ $4.36, valued at
$640.9k
Granted 150,000 options to buy
@ $4.36, valued at
$654k
|
|
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 9,900 shares
@ $4.9994, valued at
$49.5k
|
|
| 01/25/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 9,900 shares
@ $4.9994, valued at
$49.5k
|
|
| 01/25/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 9,900 shares
@ $4.9994, valued at
$49.5k
|
|
| 01/25/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 9,900 shares
@ $4.9994, valued at
$49.5k
|
|
| 01/23/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 37,639 shares
@ $4.9976, valued at
$188.1k
Bought 500 shares
@ $4.996, valued at
$2.5k
|
|
| 01/23/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 37,639 shares
@ $4.9976, valued at
$188.1k
Bought 500 shares
@ $4.996, valued at
$2.5k
|
|
| 01/23/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 37,639 shares
@ $4.9976, valued at
$188.1k
Bought 500 shares
@ $4.996, valued at
$2.5k
|
|
| 01/23/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 37,639 shares
@ $4.9976, valued at
$188.1k
Bought 500 shares
@ $4.996, valued at
$2.5k
|
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 5,378 shares
@ $4.9466, valued at
$26.6k
|
|
| 01/17/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 5,378 shares
@ $4.9466, valued at
$26.6k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 100,070 shares
@ $4.8418, valued at
$484.5k
Bought 209,000 shares
@ $4.76, valued at
$994.8k
|
|
| 01/12/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 100,070 shares
@ $4.8418, valued at
$484.5k
Bought 209,000 shares
@ $4.76, valued at
$994.8k
|
|
| 01/12/2023 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 100,070 shares
@ $4.8418, valued at
$484.5k
Bought 209,000 shares
@ $4.76, valued at
$994.8k
|
|
| 01/12/2023 |
4
| GOEDDEL DAVID V (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 100,070 shares
@ $4.8418, valued at
$484.5k
Bought 209,000 shares
@ $4.76, valued at
$994.8k
|
|
| 12/14/2022 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 300 shares
@ $4.9767, valued at
$1.5k
|
|
| 12/14/2022 |
4
| COLUMN GROUP L P (10% Owner) has filed a Form 4 on NGM BIOPHARMACEUTICALS INC|
Txns:
| Bought 300 shares
@ $4.9767, valued at
$1.5k
|
|
|